Esperal: A Clinically Proven Aid for Alcohol Dependence Management
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.13 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $82.26 $66.21 (20%) | 🛒 Add to cart |
| 90 | $1.01 | $123.39 $91.29 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $164.52 $117.37 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $246.78 $168.53 (32%) | 🛒 Add to cart |
| 270 | $0.90 | $370.16 $243.77 (34%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $493.55 $318.00 (36%) | 🛒 Add to cart |
Synonyms | |||
Esperal (disulfiram) is a prescription medication used as an integral component in the comprehensive management of chronic alcohol dependence. It functions as an aversive agent, creating a highly unpleasant physiological reaction when alcohol is consumed, thereby supporting patients in maintaining abstinence. This pharmacological deterrent is designed for use within a structured treatment program that includes counseling and psychosocial support. Clinical evidence supports its role in reinforcing commitment to sobriety, particularly when patient motivation is supported by professional oversight.
Features
- Active ingredient: Disulfiram 500 mg (standard tablet)
- Mechanism: Inhibits aldehyde dehydrogenase, leading to acetaldehyde accumulation upon alcohol ingestion
- Administration: Oral tablet, typically taken once daily
- Bioavailability: 80-95% following oral administration
- Half-life: 60-120 hours (active metabolites may persist longer)
- Onset of action: Therapeutic effect begins within 12 hours of administration
- Duration of effect: May persist for up to 14 days after discontinuation
- Formulation: Film-coated tablets for ease of swallowing
Benefits
- Creates a powerful psychological deterrent against alcohol consumption through conditioned aversion
- Provides a tangible pharmacological “safety net” during vulnerable periods in recovery
- Supports development of new behavioral patterns by removing alcohol as an option
- Enhances engagement in concurrent psychosocial therapies by maintaining abstinence
- Reduces frequency of relapse episodes when used as directed under medical supervision
- Empowers patients with an active tool in their recovery journey
Common use
Esperal is indicated as a supportive treatment in the management of chronic alcohol dependence in patients who want to remain in a state of enforced sobriety. It is prescribed for adults who have undergone detoxification and are committed to maintaining abstinence. The medication is typically incorporated into comprehensive treatment programs that include medical supervision, counseling, and social support. Patients must be fully informed about the disulfiram-alcohol reaction and provide explicit consent before initiation. Treatment is generally recommended for periods sufficient to establish stable sobriety patterns, often ranging from several months to a year, with periodic reevaluation of continued need.
Dosage and direction
Initial dosage: 500 mg orally once daily for the first 1-2 weeks
Maintenance dosage: 250 mg daily (range 125-500 mg based on individual tolerance and response)
Administration timing: Preferably in the morning to coincide with peak temptation periods
Duration of treatment: Minimum 3-6 months typically recommended, extendable based on clinical assessment
The medication should be initiated only after the patient has abstained from alcohol for at least 12 hours and preferably longer. A baseline transaminase level should be established before treatment begins. Tablets should be swallowed whole with water and may be taken with food if gastrointestinal discomfort occurs. Dosage adjustments should be made under medical supervision based on patient response and tolerance.
Precautions
- Medical supervision: Treatment must be initiated and monitored by physicians experienced in addiction medicine
- Liver function monitoring: Regular assessment of hepatic enzymes (every 2-4 weeks initially, then quarterly) is mandatory
- Patient education: Comprehensive counseling about the disulfiram-alcohol reaction must be provided and documented
- Cardiovascular assessment: Baseline ECG recommended due to potential cardiovascular effects
- Psychiatric monitoring: Regular assessment of mental status as disulfiram may exacerbate certain psychiatric conditions
- Pregnancy and breastfeeding: Contraindicated unless compelling clinical circumstances exist
- Concurrent conditions: Use with caution in patients with diabetes, hypothyroidism, epilepsy, or renal impairment
- Informed consent: Patients must provide explicit agreement after understanding all risks and benefits
Contraindications
- Known hypersensitivity to disulfiram or any tablet components
- Severe myocardial disease or coronary artery disease
- Psychosis or severe personality disorder without adequate psychiatric support
- Pregnancy and lactation (unless compelling clinical indication exists)
- Concurrent use of alcohol-containing products (including medications, foods, and toiletries)
- Severe hepatic impairment (Child-Pugh Class C) or active hepatitis
- Concurrent administration with metronidazole, paraldehyde, or certain antiretroviral medications
- Patients unable to provide informed consent or comply with treatment requirements
Possible side effects
Common (≥1/100):
- Drowsiness, fatigue, and lethargy (typically diminish with continued use)
- Metallic or garlic-like aftertaste
- Mild skin eruptions or allergic dermatitis
- Headache, which usually resolves within the first week
Less common (≥1/1000):
- Hepatotoxicity (elevated transaminases, jaundice)
- Peripheral neuropathy (numbness, paresthesia in extremities)
- Optic neuritis or visual disturbances
- Psychiatric effects including depression, anxiety, or psychosis
Rare (<1/1000):
- Severe hepatitis or hepatic failure
- Polyneuritis with potential for permanent neurological damage
- Allergic reactions including angioedema
- Cardiovascular effects including arrhythmias
Drug interaction
- Alcohol-containing products: Medications, mouthwashes, elixirs, and even topical preparations containing alcohol may trigger reaction
- Phenytoin: Disulfiram inhibits metabolism, increasing phenytoin levels and toxicity risk
- Warfarin: Potentiates anticoagulant effect requiring frequent INR monitoring
- Benzodiazepines: Metabolism may be inhibited, increasing sedative effects
- Tricyclic antidepressants: Possible increased levels and side effects
- Theophylline: Metabolism inhibited, requiring dosage adjustment
- Isoniazid: Increased risk of neurological side effects
- Metronidazole: Concurrent use contraindicated due to psychotic reactions risk
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Patients should maintain a consistent dosing routine and use reminder systems if necessary. The long half-life of disulfiram provides some buffer against occasional missed doses, but consistency is important for maintaining the aversive barrier.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, neurological symptoms, and in severe cases, cardiovascular collapse. Management is primarily supportive with gastric lavage if presentation is early. Activated charcoal may be administered. Cardiovascular support including fluids and vasopressors may be necessary. There is no specific antidote. Hemodialysis is not effective due to high protein binding. Patients should be monitored for hepatic and neurological complications for several days following overdose.
Storage
Store at room temperature (15-30°C) in the original container with the lid tightly closed. Protect from light and moisture. Keep out of reach of children and pets. Do not transfer to other containers. Discard any medication that has expired or shows signs of deterioration. Do not flush medications down the toilet or pour down the drain unless instructed to do so.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Esperal is a prescription medication that must be used under direct medical supervision. Individual response to medication may vary. Patients should consult their healthcare provider for personalized medical advice and before making any changes to their treatment regimen. The disulfiram-alcohol reaction can be severe and potentially life-threatening—strict alcohol avoidance is essential throughout treatment and for up to 14 days after discontinuation.
Reviews
Clinical studies demonstrate that when used as part of a comprehensive treatment program, disulfiram significantly improves abstinence rates compared to placebo. Patient experiences vary widely, with many reporting that the knowledge of the potential reaction provides crucial psychological support during recovery. Success appears highest when patients are highly motivated and receive consistent professional support. Some patients report side effects that necessitate dosage adjustment or discontinuation. The medication is generally regarded as an effective tool when used appropriately in selected patients.